How oncology pharmacy leaders fight burnout with stay surveys, smarter schedules, and recognition—building resilient teams through loss and turnover.
|Articles|July 23, 2012
- July 2012 Digestive Health
- Volume 78
- Issue 7
Deep Breath: Optimizing Selection and Use of Medication Devices in COPD
Author(s)Kyle Copeland, PharmD
Advertisement
Kyle Copeland, PharmD
Clinical Pharmacist SpecialistParkwest Medical CenterKnoxville, Tennessee
Kyle Copeland, PharmD, has no relevant affiliations or financial relationships with commercial interests to disclose related to this activity.
Pharmacy Times Office of Continuing Professional Education Planning Staff
Judy V. Lum, MPA, Ann C. Lichti, CCMEP, and Elena Beyzarov, PharmD, have no relevant affiliations or financial relationships with commercial interests to disclose related to this activity.
Pharmacy Times Editorial
Jennifer Whartenby and David Allikas have no relevant affiliations or financial relationships with commercial interests to disclose related to this activity.
Educational Objectives
Upon completion of this educational activity, participants should be able to:
- Examine current prevalence, diagnosis, and treatment of COPD.
- Apply current guideline recommendations to improve standards of care and patient outcomes.
- Explore a patient-specific approach to managing difficult-to-treat patients with COPD.
- Discuss proper selection and use of currently available medication devices for COPD.
Target audience: Pharmacists
Type of activity: Knowledge
Release date: July 4, 2012
Expiration date: July 4, 2014
Estimated time to complete activity: 2 hours
Fee: This lesson is free online.
Click
Articles in this issue
over 14 years ago
Health App Wrapover 14 years ago
Generic Drug Act Awaits Final Approvalover 14 years ago
FDA Policies Source of Drug Shortages, House Committee Reportsover 14 years ago
Generic Product Newsover 14 years ago
Can You Read These Rxs?over 14 years ago
Pet Peevesover 14 years ago
Case Studiesover 14 years ago
Rx Drop Boxes: Do They Work?over 14 years ago
Revocation of Pharmacist's License Reviewed by Appellate Courtover 14 years ago
Moonlighting Pharmacists: More Than 9 to 5Advertisement
Related to this article
At-home chemotherapy for HR+ breast cancer works best when pharmacists guide oral regimens, boosting adherence, safety, and affordable access.
Managing medication safety in specialized populations requires a shift from standardized dosing to precise, patient-specific customization.
Sometimes, a breakthrough matters not only because of what it does for patients today, but because of what it makes possible for tomorrow.
Pharmacogenomic-guided prescribing uses genetic data to protect patients from dangerous toxicities and get them the right drug at the right dose from the start.
As accessible health care providers, pharmacists can raise awareness about the proper use of OTC blood glucose meters and continuous glucose monitoring devices.
Growing evidence points to gallstones and cholecystitis as an underrecognized risk of GLP-1 RA therapy—pharmacists are well positioned to catch it early.
Investigational inhaled stem cells for COPD raise questions about lasting clinical benefit and the pharmacy controls needed to deliver a living-cell product through a nebulizer.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pneumonic Plague: What Pharmacists Need to Know About Treatment
2
FDA Approves First Once-Monthly Subcutaneous Olanzapine LAI for Adults With Schizophrenia
3
FDA Approves Pritelivir for Refractory HSV Lesions in Immunocompromised Adults
4
Could Cemdisiran Keep Patients With Myasthenia Gravis Out of the Hospital?
5